The number of children who are unvaccinated against measles has increased since the COVID-19 pandemic, with some counted among the cases and related deaths that spiked last year, 25 years after the viral illness was declared extinct in the US.
A recent investigation of possible factors for children not receiving measles, mumps, rubella (MMR) vaccine by the age of 2 has found an association with delayed or missed standard infant vaccinations at 2- and 4- months.1
"This finding highlights very early opportunities for intervention to address vaccine delay and potentially get children back on track," indicate Nina Masters, PhD, MPH, and colleagues at Truveta Research, Truveta Inc, Bellevue, WA.
The investigators accessed electronic health records for 321,743 children born from 2017 to 2023 with regular access to care, from the Truveta database of multiple US health systems comprising over 120 million anonymized patient records from over 900 hospitals and 20,000 clinics. The records included child visits to clinics at 0 to 2 months, 3 to 11 months, 12 to 21 months and 22 to 25 months.
In addition to demographic data, the investigation ascertained receipt of the 2- and 4-month vaccine series (Hib, DTaP, PCV, IPV, and rotavirus), and created composite timeliness indicators of appropriate vaccination at each age period.The investigators found that 157,427 (48.9%) children had adhered to the American Academy of Pediatrics (AAP) recommended well child visit schedule in the first 2 years of life.